Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $522M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CINCOR PHARMA INC | 4,937,646 | $162M | 31.0% | $19.40 | — | COM | 17240Y109 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $69.48M | 13.3% | $17.12 | — | COM | 29384C108 |
| — | RALLYBIO CORP | 3,730,724 | $53.98M | 10.3% | $17.58 | — | COM | 75120L100 |
| — | PEAR THERAPEUTICS INC | 16,903,603 | $34.48M | 6.6% | $6.20 | — | CLASS A COM | 704723105 |
| — | AKOUOS INC | 4,135,784 | $27.96M | 5.4% | $22.50 | — | COM | 00973J101 |
| — | VOR BIOPHARMA INC | 6,361,723 | $25.32M | 4.9% | $43.10 | — | COM | 929033108 |
| — | SCPHARMACEUTICALS INC | 3,334,852 | $21.74M | 4.2% | $5.92 | — | COM | 810648105 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,196,298 | $17.85M | 3.4% | $7.13 | +82.1% | COM | 45166A102 |
| ARVN | ARVINAS INC | 400,000 | $17.8M | 3.4% | $29.28 | +65.8% | COM | 04335A105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 862,286 | $16.93M | 3.2% | $19.04 | +7.1% | COM | 22663K107 |
| — | IMPEL NEUROPHARMA INC | 2,884,791 | $14.05M | 2.7% | $8.85 | — | COM | 45258K109 |
| COGT | COGENT BIOSCIENCES INC | 790,440 | $11.79M | 2.3% | $6.91 | +98.3% | COM | 19240Q201 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 484,891 | $9.945M | 1.9% | $17.98 | 0.0% | COM | 92790C104 |
| — | IVERIC BIO INC | 508,847 | $9.129M | 1.7% | $16.46 | — | COM | 46583P102 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $7.303M | 1.4% | $20.70 | — | COM | 438083107 |
| RNAM | AVIDITY BIOSCIENCES INC | 390,555 | $6.378M | 1.2% | $21.74 | -12.0% | COM | 05370A108 |
| JANX | JANUX THERAPEUTICS INC | 446,266 | $6.042M | 1.2% | $22.27 | -40.0% | COM | 47103J105 |
| PHVS | PHARVARIS N V | 587,600 | $4.507M | 0.9% | $18.63 | -16.3% | COM | N69605108 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3.651M | 0.7% | $10.17 | — | COM CL A | 33836P105 |
| — | GEMINI THERAPEUTICS INC | 524,500 | $860K | 0.2% | $1.64 | — | COM | 36870G105 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $712K | 0.1% | $3.84 | — | COM | 171757107 |